U. Hadding - Concepedia

Author

U. Hadding

Johannes Gutenberg University Mainz

Also Known As

U HADDING, U Hadding, U. HADDING, U. Hadding, ULRICH HADDING, Ulrich Hadding

187

Publications

4.9K

Citations

H-Index

138

Concepts

All Affiliations

Johannes Gutenberg University Mainz Heinrich Heine University Düsseldorf University Medical Center of the Johannes Gutenberg University Mainz Novartis (Switzerland)Utrecht University

About

U. Hadding is an author at Johannes Gutenberg University Mainz specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	70	3.2K
2	Natural Sciences	10	10	375
3	Health Sciences	6	6	364
4	Social Sciences	4	4	277
5	Engineering	1	1	36

U. Hadding

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus F.-J. Schmitz, Ad C. Fluit, Marc Lückefahr, Journal of Antimicrobial Chemotherapy Staphylococcus AureusIn-vitro ActivitiesPharmacotherapyAntimicrobial ChemotherapyAntibiotic Resistance	1998	159
Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B Willy A. Flegel, Frank Müller, Walter Däubener, Infection and Immunity InflammationCytokineMicrobial ToxinImmunotoxicologyClostridium Difficile	1991	156
Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity Werner Englberger, U. Hadding, E. Etschenberg, International Journal of Immunopharmacology InflammationComplement C3-convertaseAnti-inflammatoryMedicineRosmarinic Acid	1988	130
Characterization of <i>grlA</i> , <i>grlB</i> , <i>gyrA</i> , and <i>gyrB</i> Mutations in 116 Unrelated Isolates of <i>Staphylococcus aureus</i> and Effects of Mutations on Ciprofloxacin MIC Franz‐Josef Schmitz, Mark E. Jones, B. Hofmann, Antimicrobial Agents and Chemotherapy Unrelated IsolatesMicrobial PathogensKlebsiella PneumoniaeStaphylococcus AureusAntibiotic Resistance	1998	128
Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related C. von Eichel-Streiber, U. Harperath, Diane Bosse, Microbial Pathogenesis Microbial ToxinToxinologyClostridium DifficilePathogenesisBacteriology	1987	112
Cytokine responses induced by <i>Toxoplasma gondii</i> in astrocytes and microglial cells Hans‐Georg Fischer, B. Nitzgen, Gaby Reichmann, European Journal of Immunology	1997	106
The ninth component of human complement: isolation, description and mode of action. U. Hadding, Hans J. Müller‐Eberhard PubMed	1969	104
A new, simple, bioassay for human IFN-γ Walter Däubener, Nicole Wanagat, Korinna Pilz, Journal of Immunological Methods Laboratory ImmunologyBioanalysisImmunologyHuman Ifn-γImmunochemistry	1994	102
Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. A. Heyll, G. Meckenstock, C. Aul, PubMed	1994	99
<i>In vitro</i> synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages Carolyn Bentley, D Bitter-Suermann, U. Hadding, European Journal of Immunology Innate Immune SystemImmunologyImmune RegulationImmunologic MechanismInnate Immunity	1976	96

Page 1